Specific Diagnostics snags $12.5 mln
Silicon Valley-based Specific Diagnostics, a developer of in- vitro diagnostic systems for the detection and identification of microorganisms, has secured $12.5 million in funding. The investor was Telegraph Hill Partners.
6 September 2019•2 mins read
